8
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Mg2+ enhances high affinity [3H]8-HYDROXY-2-(DI-N-PROPYLAMINO) tetralin binding and guanine nucleotide modulation of serotonin-1a receptors

&
Pages 757-771 | Published online: 26 Sep 2008
 

Abstract

The effects of MgCl2 on the binding of the serotonin 1a (5HT1a) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin ([3H]8-OH-DPAT) to bovine hippocampal membranes were investigated. MgCl2 was found to enhance both [3H]8-OH-DPAT binding and guanine nucleotide modulation of high affinity binding. The effect of Mg2+ on promoting high affinity agonist binding was due to a 3.3 fold decrease in the dissociation constant rather than an increase in the number of binding sites. Mg2+ acted to increase the efficacy of the nonhydrolyzable GTP analog 5′ guanylylimidodiphosphate (GppNHp) in promoting the interconversion of high and low affinity states. Addition of MgCl2 significantly increased the sensitivity of [3H]8-OH-DPAT binding to GppNHp, decreasing the concentration needed for half-maximal inhibition of binding from greater than 50 µM to 300 nM. Our findings that Mg2+ enhances high affinity [3H]8-OH-DPAT binding without change in number of binding sites and that guanine nucleotide modulation of binding can occur in the absence of Mg2+ suggests that ternary complex formation between receptor, ligand and G-protein can occur in the absence of Mg2+.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.